Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

SHE:002550 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	439.95	576.23	409.26	617.81	516.11
Short-Term Investments	192.9	64.95	-	-	-
Trading Asset Securities	273.83	71.98	67.48	68.23	234.28
Cash & Short-Term Investments	906.67	713.16	476.73	686.03	750.39
Cash Growth	27.13%	49.59%	-30.51%	-8.58%	-13.35%
Accounts Receivable	274.25	275.52	632.87	447.67	461.88
Other Receivables	23.24	16.9	2.48	2.56	4.81
Receivables	297.48	292.42	635.35	450.23	466.69
Inventory	426.81	602.01	536.48	400.63	315.97
Prepaid Expenses	-	-	-	0.01	0.01
Other Current Assets	62.73	18.39	38.72	33.04	23.96
Total Current Assets	1,694	1,626	1,687	1,570	1,557
Property, Plant & Equipment	563.6	561.27	616.39	611.77	599.56
Long-Term Investments	160.08	203.22	156.78	40.56	6.71
Goodwill	11.14	11.14	11.14	11.14	11.14
Other Intangible Assets	109.32	113.14	100.86	106.92	114.42
Long-Term Deferred Tax Assets	75.26	90.53	101.49	99.42	105.52
Long-Term Deferred Charges	138.04	93.77	60.33	46.85	38.14
Other Long-Term Assets	79.31	67.05	71.67	21.81	19.27
Total Assets	2,830	2,766	2,806	2,508	2,452
Accounts Payable	88.64	41.18	45.97	71.23	106.25
Accrued Expenses	88.06	89.7	101.94	99.55	96.63
Short-Term Debt	21.49	56.31	103.05	93.56	41.85
Current Income Taxes Payable	1.53	0.64	0.05	-	15.02
Current Unearned Revenue	9.68	9.71	15.58	19.67	11.86
Other Current Liabilities	14	8.28	11.63	12.34	19.38
Total Current Liabilities	223.39	205.81	278.22	296.35	290.98
Long-Term Unearned Revenue	86.46	81.85	89.35	93.42	94.87
Long-Term Deferred Tax Liabilities	4.02	4.52	4.96	0.47	0.5
Total Liabilities	313.87	292.17	372.53	390.24	386.35
Common Stock	1,280	1,280	1,280	1,280	1,280
Additional Paid-In Capital	41.65	41.65	36.29	29.38	25.58
Retained Earnings	1,369	1,163	1,134	960.89	929.79
Treasury Stock	-170.86	-30.09	-	-145.05	-154.38
Comprehensive Income & Other	-2.42	0.36	-0.06	2.23	-0.88
Total Common Equity	2,517	2,455	2,450	2,127	2,080
Minority Interest	-0.87	18.98	-16.95	-9.09	-14.56
Shareholders' Equity	2,517	2,474	2,433	2,118	2,065
Total Liabilities & Equity	2,830	2,766	2,806	2,508	2,452
Total Debt	21.49	56.31	103.05	93.56	41.85
Net Cash (Debt)	885.19	656.85	373.69	592.48	708.54
Net Cash Growth	34.76%	75.78%	-36.93%	-16.38%	35.81%
Net Cash Per Share	0.70	0.51	0.29	0.49	0.59
Filing Date Shares Outstanding	1,250	1,275	1,280	1,280	1,280
Total Common Shares Outstanding	1,250	1,275	1,280	1,280	1,280
Working Capital	1,470	1,420	1,409	1,274	1,266
Book Value Per Share	2.01	1.93	1.91	1.66	1.63
Tangible Book Value	2,397	2,331	2,338	2,009	1,954
Tangible Book Value Per Share	1.92	1.83	1.83	1.57	1.53
Buildings	498.75	498.75	525.73	524.28	448.65
Machinery	568.44	558.3	504.84	461.29	426.63
Construction In Progress	61.25	8.19	54.1	39.24	76.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.